Dr. Julie Graff, M.D
NPI: 1942445952
Total Payments
$60,054
2022 Payments
$1,270
Companies
13
Transactions
77
Medicare Patients
338
Medicare Billing
$77,116
Payment Breakdown by Category
Consulting$31,638 (52.7%)
Travel$17,231 (28.7%)
Other$7,625 (12.7%)
Food & Beverage$2,276 (3.8%)
Research$1,270 (2.1%)
Education$13.34 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,638 | 8 | 52.7% |
| Travel and Lodging | $17,231 | 23 | 28.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,625 | 5 | 12.7% |
| Food and Beverage | $2,276 | 38 | 3.8% |
| Unspecified | $1,270 | 2 | 2.1% |
| Education | $13.34 | 1 | 0.0% |
Payments by Type
General
$58,784
75 transactions
Research
$1,270
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $20,759 | 18 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $16,652 | 13 | $0 (2017) |
| Janssen Biotech, Inc. | $6,656 | 12 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $3,412 | 3 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $2,540 | 6 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $2,304 | 8 | $0 (2019) |
| Janssen Global Services, LLC | $2,280 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $1,667 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $1,495 | 7 | $0 (2020) |
| PFIZER INC. | $1,283 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,270 | 2 | PFIZER INC. ($1,270) |
| 2021 | $30.41 | 1 | Myriad Genetic Laboratories, Inc. ($30.41) |
| 2020 | $187.30 | 4 | Merck Sharp & Dohme Corporation ($173.96) |
| 2019 | $4,345 | 9 | SANOFI-AVENTIS U.S. LLC ($1,870) |
| 2018 | $13,205 | 9 | GENZYME CORPORATION ($11,518) |
| 2017 | $41,015 | 52 | Bayer HealthCare Pharmaceuticals Inc. ($16,652) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2022 | PFIZER INC. | XTANDI (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 04/13/2022 | PFIZER INC. | XTANDI (Drug) | — | In-kind items and services | $330.00 | Research |
| Study: ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 03/17/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $30.41 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 09/15/2020 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $64.98 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $54.49 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $54.49 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $239.69 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $190.26 | General |
| 09/30/2019 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,340.00 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2019 | F. Hoffmann-La Roche AG | TECENTRIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $724.29 | General |
| Category: BioOncology | ||||||
| 06/30/2019 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $530.00 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $910.43 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $302.06 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $66.72 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | Cash or cash equivalent | $41.75 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Travel and Lodging | In-kind items and services | $10,638.81 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Travel and Lodging | In-kind items and services | $601.73 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $60.64 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $39.21 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $39.21 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $138.23 | General |
| 02/09/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.22 | General |
| 02/08/2018 | Astellas Pharma US Inc | ENZALUTAMIDE (Drug) | Consulting Fee | Cash or cash equivalent | $1,560.00 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2018 | Astellas Pharma US Inc | ENZALUTAMIDE (Drug) | Food and Beverage | In-kind items and services | $107.42 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,270 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 75 | 127 | $39,071 | $9,980 |
| 2022 | 1 | 12 | 34 | $5,440 | $5,430 |
| 2021 | 5 | 109 | 244 | $48,461 | $27,828 |
| 2020 | 6 | 142 | 336 | $58,797 | $33,877 |
Total Patients
338
Total Services
741
Medicare Billing
$77,116
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 102 | $29,496 | $7,612 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $9,575 | $2,368 | 24.7% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2022 | 12 | 34 | $5,440 | $5,430 | 99.8% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2021 | 25 | 117 | $18,720 | $18,750 | 100.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 55 | $12,890 | $4,126 | 32.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 24 | $7,458 | $2,874 | 38.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 24 | 34 | $7,086 | $1,418 | 20.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 14 | $2,307 | $660.12 | 28.6% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2020 | 28 | 161 | $25,760 | $25,689 | 99.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 89 | $18,036 | $4,810 | 26.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 23 | 38 | $7,075 | $1,523 | 21.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 15 | $3,942 | $983.97 | 25.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 13 | $1,870 | $465.87 | 24.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 16 | 20 | $2,114 | $405.45 | 19.2% |
About Dr. Julie Graff, M.D
Dr. Julie Graff, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942445952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Graff, M.D has received a total of $60,054 in payments from pharmaceutical and medical device companies, with $1,270 received in 2022. These payments were reported across 77 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($31,638).
As a Medicare-enrolled provider, Graff has provided services to 338 Medicare beneficiaries, totaling 741 services with total Medicare billing of $77,116. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Medical Oncology, Internal Medicine
- Location Portland, OR
- Active Since 12/04/2008
- Last Updated 08/20/2014
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1942445952
Products in Payments
- JEVTANA (Drug) $21,942
- Xofigo (Drug) $16,652
- PROVENGE (Drug) $3,412
- ENZALUTAMIDE (Drug) $1,667
- KEYTRUDA (Biological) $1,495
- XTANDI (Drug) $1,270
- NO PRODUCT DISCUSSED (Drug) $1,002
- TECENTRIQ (Biological) $955.06
- ZYTIGA (Drug) $155.88
- DARZALEX (Biological) $130.04
- TAXOTERE (Drug) $118.45
- Prolaris (Device) $30.41
- INLYTA (Drug) $13.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Portland
Amanda Vansandt, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $280,593
Student in an Organized Health Care Education/Training Program $280,593
Mathew Geltzeiler, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $186,613
Student in an Organized Health Care Education/Training Program $186,613
Josha Woodward
Student in an Organized Health Care Education/Training Program — Payments: $99,642
Student in an Organized Health Care Education/Training Program $99,642
Trevor Crafts, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $50,126
Student in an Organized Health Care Education/Training Program $50,126
Adel Kardosh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,266
Student in an Organized Health Care Education/Training Program $40,266
Sriram Ravi, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,134
Student in an Organized Health Care Education/Training Program $30,134